Evaluation and Comparison of Tools for Diagnosing Problematic Prescription Opioid Use Among Chronic Pain Patients

Overview

Journal Int J Methods Psychiatr Res

Specialty Psychiatry

Date 2016 Oct 25

PMID 27774717

Citations 3

Authors

Merav Kovatch

Daniel Feingold

Odelia Elkana

Shaul Lev-Ran

Affiliations

Soon will be listed here.

Abstract

Prescription opioid medications are commonly used for the treatment of chronic pain. Assessments of problematic opioid use among pain patients are inconsistent across studies, partially due to differences between various measures. Therefore, the most appropriate measure to use is often unclear. In this study we assessed problematic opioid use in a sample of 551 individuals receiving treatment for chronic pain, using three questionnaires: the Alcohol Use Disorder and Associated Disabilities Interview Schedule - Fourth Edition (AUDADIS-IV), the Current Opioid Misuse Measure (COMM) questionnaire and Portenoy's criteria (PC). These questionnaires yielded discordant positive rates of problematic use: 52.6%, 28.7%, and 17.1%, respectively, which did not change substantially when excluding AUDADIS-IV criteria of physical symptoms of tolerance and withdrawal. Although these three questionnaires share some statistically correlated content-based congruent questions, positive response rates to them were significantly different based on construction features, including questionnaires' referred time-frame, wording of questions and response alternatives. The findings of the present study illustrate strengths and limitations of the AUDADIS-IV, COMM and PC in diagnosing problematic opioid use in a population of adults suffering from chronic pain, and highlight the importance of recognizing and addressing specific questionnaire and question-related differences when identifying problematic opioid use in this population.

Citing Articles

Identifying problematic opioid use in electronic health record data: Are we looking in the right place?.

Schirle L, Kwun S, Suh A, Sanchez-Roige S, Jeffery A, Samuels D J Opioid Manag. 2023; 19(1):5-9.

PMID: 36683296 PMC: 9987029. DOI: 10.5055/jom.2023.0754.

Two data-driven approaches to identifying the spectrum of problematic opioid use: A pilot study within a chronic pain cohort.

Schirle L, Jeffery A, Yaqoob A, Sanchez-Roige S, Samuels D Int J Med Inform. 2021; 156:104621.

PMID: 34673309 PMC: 8609775. DOI: 10.1016/j.ijmedinf.2021.104621.

Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Kovatch M, Feingold D, Elkana O, Lev-Ran S Int J Methods Psychiatr Res. 2016; 26(4).

PMID: 27774717 PMC: 6877121. DOI: 10.1002/mpr.1542.

References

Edwards A . Social desirability and probability of endorsement of items in the interpersonal check list. J Abnorm Psychol. 1957; 55(3):394-6. DOI: 10.1037/h0048497. View

Passik S, Kirsh K, Whitcomb L, Portenoy R, Katz N, Kleinman L . A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004; 26(4):552-61. DOI: 10.1016/s0149-2918(04)90057-4. View

Portenoy R . Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996; 11(4):203-17. DOI: 10.1016/0885-3924(95)00187-5. View

Sehgal N, Manchikanti L, Smith H . Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012; 15(3 Suppl):ES67-92. View

Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W . Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008; 46(3):266-74. DOI: 10.1097/MLR.0b013e318160d093. View

Hojsted J, Sjogren P . Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2006; 11(5):490-518. DOI: 10.1016/j.ejpain.2006.08.004. View

Wilson J . Strategies to stop abuse of prescribed opioid drugs. Ann Intern Med. 2007; 146(12):897-900. DOI: 10.7326/0003-4819-146-12-200706190-00017. View

Segura-Garcia C, Aloi M, Rania M, Ciambrone P, Palmieri A, Pugliese V . Ability of EDI-2 and EDI-3 to correctly identify patients and subjects at risk for eating disorders. Eat Behav. 2015; 19:20-3. DOI: 10.1016/j.eatbeh.2015.06.010. View

Roxburgh A, Bruno R, Larance B, Burns L . Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011; 195(5):280-4. DOI: 10.5694/mja10.11450. View

10.

Harrison L . The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997; 167:17-36. View

11.

Pergolizzi Jr J, Gharibo C, Passik S, Labhsetwar S, Taylor Jr R, Pergolizzi J . Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012; 72(6):443-51. DOI: 10.1016/j.jpsychores.2012.02.009. View

12.

Ives T, Chelminski P, Hammett-Stabler C, Malone R, Perhac J, Potisek N . Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006; 6:46. PMC: 1513222. DOI: 10.1186/1472-6963-6-46. View

13.

Manchikanti K, Manchikanti L, Damron K, Pampati V, Fellows B . Increasing deaths from opioid analgesics in the United States: an evaluation in an interventional pain management practice. J Opioid Manag. 2008; 4(5):271-83. DOI: 10.5055/jom.2008.0031. View

14.

Maske U, Buttery A, Beesdo-Baum K, Riedel-Heller S, Hapke U, Busch M . Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany. J Affect Disord. 2015; 190:167-177. DOI: 10.1016/j.jad.2015.10.006. View

15.

Mewton L, Slade T, McBride O, Grove R, Teesson M . An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data. Addiction. 2011; 106(5):941-50. DOI: 10.1111/j.1360-0443.2010.03340.x. View

16.

Martins S, Keyes K, Storr C, Zhu H, Chilcoat H . Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009; 103(1-2):16-24. PMC: 2699563. DOI: 10.1016/j.drugalcdep.2009.01.019. View

17.

Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

18.

Scott-Sheldon L, Carey K, Carey M, Cain D, Simbayi L, Kalichman S . Alcohol use disorder, contexts of alcohol use, and the risk of HIV transmission among South African male patrons of shebeens. Drug Alcohol Depend. 2014; 140:198-204. PMC: 4079048. DOI: 10.1016/j.drugalcdep.2014.04.022. View

19.

Grant B, Harford T, Dawson D, CHOU P, Pickering R . The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995; 39(1):37-44. DOI: 10.1016/0376-8716(95)01134-k. View

20.

Fischer B, Argento E . Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012; 15(3 Suppl):ES191-203. View